Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | NovaLead |
Description | RESEARCH FOCUS and NovaLead Pharma Pvt. Ltd. is a company based out of Pune, India specialising in drug |
Keywords | NovaLead,Pharma,Drug Repositioning,drug discovery,DFU,diabetic,foot,ulcer,virtual screening platform,drug repurposing,Galnobax |
WebSite | novaleadpharma.com |
Host IP | 139.162.5.236 |
Location | Australia |
Site | Rank |
US$1,061
Last updated: 2023-05-08 23:02:03
novaleadpharma.com has Semrush global rank of 0. novaleadpharma.com has an estimated worth of US$ 1,061, based on its estimated Ads revenue. novaleadpharma.com receives approximately 122 unique visitors each day. Its web server is located in Australia, with IP address 139.162.5.236. According to SiteAdvisor, novaleadpharma.com is safe to visit. |
Purchase/Sale Value | US$1,061 |
Daily Ads Revenue | US$0 |
Monthly Ads Revenue | US$29 |
Yearly Ads Revenue | US$352 |
Daily Unique Visitors | 8 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
novaleadpharma.com. | A | 599 | IP: 139.162.5.236 |
novaleadpharma.com. | NS | 3600 | NS Record: ns68.domaincontrol.com. |
novaleadpharma.com. | NS | 3600 | NS Record: ns67.domaincontrol.com. |
novaleadpharma.com. | MX | 3600 | MX Record: 30 ALT2.ASPMX.L.GOOGLE.com. |
novaleadpharma.com. | MX | 3600 | MX Record: 10 ASPMX.L.GOOGLE.com. |
novaleadpharma.com. | MX | 3600 | MX Record: 40 ASPMX2.GOOGLEMAIL.com. |
novaleadpharma.com. | MX | 3600 | MX Record: 50 ASPMX3.GOOGLEMAIL.com. |
novaleadpharma.com. | MX | 3600 | MX Record: 20 ALT1.ASPMX.L.GOOGLE.com. |
About Us Board Of Directors --> Management Team Pipeline Galnobax ® NLP91 Technology Partnering News / Events Careers Contact us --> 1 st Dec, 2021 Galnobax ® achieves Primary Endpoint in the Phase-3 clinical trial for the treatment of Diabetic Foot Ulcers (DFU) NovaLead has recently completed Phase-III clinical study of Galnobax ® which is its flagship product which is a repurposed drug. The Phase-III trial data analysis shows that the primary as well as secondary endpoint for percentage of subjects achieving complete ulcer closure are met with Galnobax demonstrating statistically significant superiority over the standard of care (SoC). Analysis further showed that Galnobax ® demonstrated statistically significant superiority over the standard of care (SoC) in ‘Hard to Heal’ ulcers as well. The safety analysis showed that Galnobax® is safe for long term use. NovaLead is a drug discovery research company focused on discovering new indications for generic drugs. Enabled |
HTTP/1.1 301 Moved Permanently Date: Sat, 30 Oct 2021 20:29:13 GMT Server: Apache/2.4.29 (Ubuntu) Location: https://novaleadpharma.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Sat, 30 Oct 2021 20:29:13 GMT Server: Apache/2.4.29 (Ubuntu) Last-Modified: Thu, 28 May 2020 11:03:35 GMT ETag: "f8f4-5a6b347a88ced" Accept-Ranges: bytes Content-Length: 63732 Vary: Accept-Encoding Content-Type: text/html |
Domain Name: NOVALEADPHARMA.COM Registry Domain ID: 1226117208_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-07-31T05:33:13Z Creation Date: 2007-09-19T12:45:32Z Registry Expiry Date: 2022-09-19T12:45:32Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS67.DOMAINCONTROL.COM Name Server: NS68.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T06:47:11Z <<< |